Francesca Porrati

Nitric Oxide Synthetic Capacity in Relation to Dialysate Temperature

G. Remuzzi, K. Leunissen, M. Morigi, 2004, Blood Purification.

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

G. Remuzzi, J. Atkinson, M. Noris, 2006, Blood.

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

G. Remuzzi, M. Noris, F. Casiraghi, 2005, Thrombosis and Haemostasis.

l-Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant Species

G. Remuzzi, A. Benigni, M. Noris, 2004, Hypertension.

Familial haemolytic uraemic syndrome and an MCP mutation

G. Remuzzi, M. Noris, M. Todeschini, 2003, The Lancet.

presentation, response to treatment, and outcome Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical

G. Remuzzi, J. Atkinson, M. Noris, 2013 .

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

G. Remuzzi, M. Noris, F. Casiraghi, 2005, Thrombosis and Haemostasis.